Comparison of effectiveness of growth hormone therapy according to disease-causing genes in children with Noonan syndrome
Kyo Jin Jo (Jo KJ), Yoo Mi Kim (Kim YM), Ju Young Yoon (Yoon JY), Yeoun Joo Lee (Lee YJ), Young Mi Han (Han YM), Han-Wook Yoo (Yoo HW), Hyang-Sook Kim (Kim HS), Chong Kun Cheon (Cheon CK)
Clin Exp Pediatr. 2019;62(7):274-280.   Published online 2018 Dec 3     DOI: https://doi.org/10.3345/kjp.2018.06842
Citations to this article as recorded by Crossref logo
Activation of the MAPK pathway (RASopathies) and partial growth hormone insensitivity
Alexsandra C. Malaquias, Alexander A.L. Jorge
Molecular and Cellular Endocrinology.2021; 519: 111040.     CrossRef
Growth in Children With Noonan Syndrome and Effects of Growth Hormone Treatment on Adult Height
Annachiara Libraro, Vito D’Ascanio, Marco Cappa, Mariangela Chiarito, Maria Cristina Digilio, Silvia Einaudi, Anna Grandone, Mohamad Maghnie, Laura Mazzanti, Alessandro Mussa, Giuseppa Patti, Emanuela Scarano, Antonietta Spinuzza, Silvia Vannelli, Malgorz
Frontiers in Endocrinology.2021;[Epub]     CrossRef
Effectiveness of growth hormone therapy in children with Noonan syndrome
Eun mi Seok, Hong Kyu Park, Jung Gi Rho, Change Dae Kum, Hae Sang Lee, Jin Soon Hwang
Annals of Pediatric Endocrinology & Metabolism.2020; 25(3): 182.     CrossRef
Correlation between genetic heterogeneity and variability for response to growth hormone in Noonan syndrome
Young-Lim Shin
Korean Journal of Pediatrics.2019; 62(11): 412.     CrossRef